Index RUT P/E - EPS (ttm) -2.13 Insider Own 57.90% Shs Outstand 97.38M Perf Week -24.53%
Market Cap 727.38M Forward P/E - EPS next Y -1.51 Insider Trans 16.03% Shs Float 50.54M Perf Month 24.69%
Income -204.50M PEG - EPS next Q -0.39 Inst Own 34.64% Short Float 22.26% Perf Quarter -33.99%
Sales 0.59M P/S 1232.85 EPS this Y 25.01% Inst Trans - Short Ratio 14.74 Perf Half Y -13.80%
Book/sh 2.03 P/B 2.98 EPS next Y 7.56% ROA -65.09% Short Interest 11.25M Perf Year -55.67%
Cash/sh 1.76 P/C 3.45 EPS next 5Y - ROE -78.27% 52W Range 4.11 - 17.20 Perf YTD -31.60%
Dividend Est. - P/FCF - EPS past 5Y -193.88% ROI -72.82% 52W High -64.77% Beta 2.39
Dividend TTM - Quick Ratio 8.91 Sales past 5Y -25.00% Gross Margin -1850.08% 52W Low 47.45% ATR (14) 0.59
Dividend Ex-Date Sep 10, 2019 Current Ratio 8.91 EPS Y/Y TTM -33.33% Oper. Margin -33773.27% RSI (14) 46.28 Volatility 10.27% 9.73%
Employees 234 Debt/Eq 0.18 Sales Y/Y TTM - Profit Margin -34601.86% Recom 1.33 Target Price 14.18
Option/Short Yes / Yes LT Debt/Eq 0.15 EPS Q/Q 0.97% Payout - Rel Volume 2.07 Prev Close 6.50
Sales Surprise -69.25% EPS Surprise 3.28% Sales Q/Q - Earnings May 10 BMO Avg Volume 763.29K Price 6.06
SMA20 -4.10% SMA50 0.27% SMA200 -24.51% Trades
Volume 194,776 Change -6.77%
Date
Action
Analyst
Rating Change
Price Target Change
May-20-24 Initiated H.C. Wainwright
Buy
$10
May-16-24 Upgrade Citigroup
Neutral → Buy
$10
Apr-22-24 Initiated Chardan Capital Markets
Buy
$17
Apr-08-24 Initiated TD Cowen
Buy
Apr-03-24 Initiated Wedbush
Outperform
$12
Jan-16-24 Downgrade Stifel
Buy → Hold
$18 → $9
Dec-08-23 Initiated Citigroup
Neutral
$10
Oct-09-23 Initiated BMO Capital Markets
Outperform
$19
Jul-31-23 Initiated Guggenheim
Buy
$24
Apr-18-23 Initiated Stifel
Buy
$18
Nov-14-22 Initiated Morgan Stanley
Equal-Weight
$23
Nov-14-22 Initiated JP Morgan
Overweight
$27
Nov-14-22 Initiated Jefferies
Buy
$25
Nov-14-22 Initiated Goldman
Neutral
$22
Show Previous Ratings
Today 06:30AM
May-25-24 04:10AM
May-20-24 09:32PM
09:33AM
May-17-24 06:27AM
06:15AM
Loading…
06:15AM
May-16-24 07:14AM
May-14-24 09:55AM
May-13-24 11:12AM
08:00AM
May-12-24 03:00AM
May-10-24 02:23PM
01:53PM
08:00AM
May-08-24 08:00AM
12:00PM
Loading…
May-03-24 12:00PM
May-01-24 08:00AM
Apr-30-24 06:01AM
Apr-29-24 10:12AM
07:35AM
07:33AM
07:00AM
Apr-23-24 08:00AM
Mar-27-24 08:45AM
Mar-14-24 02:44PM
Mar-01-24 02:00PM
08:00AM
Feb-29-24 03:02AM
Feb-28-24 08:00AM
Feb-20-24 04:01PM
11:50PM
Loading…
Feb-14-24 11:50PM
04:05PM
Feb-01-24 08:00AM
Jan-25-24 08:00AM
Jan-09-24 06:21PM
Jan-05-24 05:00PM
08:00AM
Jan-02-24 08:00AM
Dec-19-23 10:30AM
Nov-30-23 07:45AM
Nov-08-23 08:00AM
Nov-03-23 04:01PM
Oct-30-23 03:46PM
Oct-27-23 06:00AM
Oct-24-23 07:30AM
05:04AM
Oct-23-23 02:50AM
Oct-17-23 08:00AM
Oct-09-23 09:33AM
Sep-19-23 08:00AM
Aug-31-23 08:00AM
Aug-07-23 04:01PM
Jul-25-23 07:45AM
Jun-29-23 08:46AM
Jun-22-23 08:00AM
Jun-02-23 10:15AM
May-31-23 08:00AM
May-26-23 09:45AM
May-17-23 04:05PM
06:00AM
May-11-23 08:00AM
Mar-27-23 08:00AM
Mar-09-23 08:00AM
Feb-27-23 08:00AM
Jan-20-23 05:56AM
Jan-09-23 07:00AM
Jan-03-23 08:00AM
Nov-01-22 04:13PM
Oct-24-22 05:30PM
Oct-20-22 12:45PM
Oct-19-22 09:47PM
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ARCH Venture Partners XII, LLC 10% Owner Feb 15 '24 Buy 6.25 3,200,000 20,000,000 3,200,000 Feb 20 05:38 PM ARCH Venture Partners X, LLC 10% Owner Feb 15 '24 Buy 6.25 3,200,000 20,000,000 3,200,000 Feb 20 05:37 PM NELSEN ROBERT Director Feb 15 '24 Buy 6.25 3,200,000 20,000,000 3,200,000 Feb 20 05:41 PM GV 2019 GP, L.L.C. 10% Owner Jun 21 '23 Sale 14.97 19,003 284,496 0 Jun 22 05:03 PM GV 2019 GP, L.L.C. 10% Owner Jun 20 '23 Sale 15.06 37,405 563,248 0 Jun 22 05:03 PM GV 2019 GP, L.L.C. 10% Owner Jun 16 '23 Sale 15.02 6,532 98,109 0 Jun 20 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 15 '23 Sale 14.92 66,659 994,326 0 Jun 20 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 14 '23 Sale 14.87 28,960 430,684 0 Jun 15 04:22 PM GV 2019 GP, L.L.C. 10% Owner Jun 13 '23 Sale 15.13 28,100 425,102 0 Jun 15 04:22 PM GV 2019 GP, L.L.C. 10% Owner Jun 12 '23 Sale 14.98 16,031 240,151 0 Jun 13 04:20 PM GV 2019 GP, L.L.C. 10% Owner Jun 09 '23 Sale 14.48 15,672 226,984 0 Jun 13 04:20 PM GV 2019 GP, L.L.C. 10% Owner Jun 08 '23 Sale 15.74 5,000 78,686 0 Jun 09 04:24 PM GV 2019 GP, L.L.C. 10% Owner Jun 07 '23 Sale 16.92 15,000 253,871 0 Jun 09 04:24 PM GV 2019 GP, L.L.C. 10% Owner Jun 06 '23 Sale 17.02 29,975 510,166 0 Jun 07 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 05 '23 Sale 16.70 22,434 374,612 0 Jun 07 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 01 '23 Sale 14.36 45,223 649,194 0 Jun 02 04:17 PM GV 2019 GP, L.L.C. 10% Owner May 31 '23 Sale 13.65 16,633 227,004 0 Jun 02 04:17 PM GV 2019 GP, L.L.C. 10% Owner May 30 '23 Sale 13.70 16,805 230,240 0 May 31 04:15 PM
Index RUT P/E - EPS (ttm) -1.62 Insider Own 66.00% Shs Outstand 158.83M Perf Week -1.32%
Market Cap 1.49B Forward P/E - EPS next Y -1.58 Insider Trans 0.00% Shs Float 54.24M Perf Month -1.43%
Income -254.02M PEG - EPS next Q -0.37 Inst Own 20.44% Short Float 11.64% Perf Quarter -47.29%
Sales 0.00M P/S - EPS this Y 59.31% Inst Trans - Short Ratio 9.67 Perf Half Y -21.70%
Book/sh 2.66 P/B 3.50 EPS next Y -6.69% ROA -60.32% Short Interest 6.31M Perf Year -
Cash/sh 2.65 P/C 3.52 EPS next 5Y - ROE -64.28% 52W Range 8.82 - 21.00 Perf YTD -45.31%
Dividend Est. - P/FCF - EPS past 5Y - ROI -59.70% 52W High -55.60% Beta -
Dividend TTM - Quick Ratio 17.99 Sales past 5Y 0.00% Gross Margin - 52W Low 5.73% ATR (14) 0.59
Dividend Ex-Date - Current Ratio 17.99 EPS Y/Y TTM -99.66% Oper. Margin 0.00% RSI (14) 40.74 Volatility 5.40% 6.05%
Employees 124 Debt/Eq 0.01 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 23.84
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q -43.81% Payout - Rel Volume 0.31 Prev Close 9.51
Sales Surprise - EPS Surprise 0.58% Sales Q/Q - Earnings May 07 BMO Avg Volume 653.25K Price 9.32
SMA20 -1.06% SMA50 -16.91% SMA200 -29.78% Trades
Volume 24,780 Change -1.95%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-12-23 Initiated Deutsche Bank
Hold
$13
Oct-10-23 Initiated William Blair
Outperform
$26
Oct-10-23 Initiated Stifel
Buy
$26
Oct-10-23 Initiated RBC Capital Mkts
Outperform
$24
Oct-10-23 Initiated JP Morgan
Overweight
$21
Oct-10-23 Initiated Guggenheim
Buy
$22
Oct-10-23 Initiated BofA Securities
Buy
$18
May-14-24 08:52AM
07:00AM
May-07-24 01:54PM
10:20AM
07:00AM
07:00AM
Loading…
May-06-24 07:00AM
Apr-16-24 11:28AM
Apr-15-24 04:20PM
(Investor's Business Daily) -17.48%
12:17PM
08:45AM
07:47AM
06:36AM
06:30AM
Mar-13-24 07:00AM
Mar-07-24 02:52PM
07:00AM
Loading…
07:00AM
Jan-22-24 07:00AM
Jan-10-24 08:32AM
Jan-02-24 07:00AM
Dec-17-23 12:35PM
Dec-12-23 07:00AM
Nov-27-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 07:00AM
Sep-28-23 07:54PM
Sep-27-23 06:50PM
Sep-18-23 12:35PM
Sep-14-23 08:49PM
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Burow Kristina Director Nov 14 '23 Buy 11.98 3,357 40,217 4,131,207 Nov 15 06:55 PM ARCH Venture Partners XII, LLC 10% Owner Nov 14 '23 Buy 11.98 3,357 40,217 4,131,207 Nov 15 06:54 PM ARCH Venture Partners XII, LLC 10% Owner Nov 13 '23 Buy 11.75 31,653 371,923 4,127,850 Nov 15 06:54 PM Burow Kristina Director Nov 13 '23 Buy 11.75 31,653 371,923 4,127,850 Nov 15 06:55 PM Burow Kristina Director Nov 10 '23 Buy 11.49 17,275 198,481 4,096,197 Nov 13 07:01 PM ARCH Venture Partners XII, LLC 10% Owner Nov 10 '23 Buy 11.49 17,275 198,481 4,096,197 Nov 13 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 09 '23 Buy 10.53 31,079 327,262 4,078,922 Nov 13 07:00 PM Burow Kristina Director Nov 09 '23 Buy 10.53 31,079 327,262 4,078,922 Nov 13 07:01 PM Burow Kristina Director Nov 08 '23 Buy 11.03 92,251 1,017,821 4,047,843 Nov 13 07:01 PM ARCH Venture Partners XII, LLC 10% Owner Nov 08 '23 Buy 11.03 92,251 1,017,821 4,047,843 Nov 13 07:00 PM Burow Kristina Director Nov 07 '23 Buy 11.50 30,192 347,208 3,955,592 Nov 07 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 07 '23 Buy 11.50 30,192 347,208 3,955,592 Nov 07 06:59 PM ARCH Venture Partners XII, LLC 10% Owner Nov 06 '23 Buy 11.55 43,082 497,597 3,925,400 Nov 07 06:59 PM Burow Kristina Director Nov 06 '23 Buy 11.55 43,082 497,597 3,925,400 Nov 07 07:00 PM Burow Kristina Director Nov 03 '23 Buy 11.38 22,420 255,140 3,882,318 Nov 07 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 03 '23 Buy 11.38 22,420 255,140 3,882,318 Nov 07 06:59 PM Burow Kristina Director Sep 29 '23 Buy 13.98 34,560 483,149 3,859,898 Sep 29 06:55 PM ARCH Venture Partners XII, LLC 10% Owner Sep 29 '23 Buy 13.98 34,560 483,149 3,859,898 Sep 29 06:53 PM ARCH Venture Partners XII, LLC 10% Owner Sep 28 '23 Buy 13.44 41,951 563,699 3,825,338 Sep 29 06:53 PM Burow Kristina Director Sep 28 '23 Buy 13.44 41,951 563,699 3,825,338 Sep 29 06:55 PM ARCH Venture Partners XII, LLC 10% Owner Sep 27 '23 Buy 12.31 24,504 301,644 3,783,387 Sep 27 08:18 PM Burow Kristina Director Sep 27 '23 Buy 12.31 24,504 301,644 3,783,387 Sep 27 08:19 PM Burow Kristina Director Sep 26 '23 Buy 11.73 34,000 398,820 3,758,883 Sep 27 08:19 PM ARCH Venture Partners XII, LLC 10% Owner Sep 26 '23 Buy 11.73 34,000 398,820 3,758,883 Sep 27 08:18 PM Burow Kristina Director Sep 25 '23 Buy 11.22 60,740 681,464 3,724,883 Sep 25 09:37 PM ARCH Venture Partners XII, LLC 10% Owner Sep 25 '23 Buy 11.22 60,740 681,464 3,724,883 Sep 25 09:38 PM ARCH Venture Partners XII, LLC 10% Owner Sep 22 '23 Buy 11.14 40,000 445,600 3,664,143 Sep 25 09:38 PM Burow Kristina Director Sep 22 '23 Buy 11.14 40,000 445,600 3,664,143 Sep 25 09:37 PM AMGEN INC 10% Owner Sep 19 '23 Buy 17.00 1,764,705 29,999,985 35,368,653 Sep 19 07:52 PM Burow Kristina Director Sep 19 '23 Buy 17.00 1,500,000 25,500,000 3,624,143 Sep 20 06:23 AM ARCH Venture Partners X, LLC 10% Owner Sep 19 '23 Buy 17.00 1,500,000 25,500,000 3,624,143 Sep 20 06:16 AM ARCH Venture Partners X, LLC 10% Owner Sep 19 '23 Buy 17.00 1,500,000 25,500,000 3,624,143 Sep 20 06:15 AM Gosebruch Henry O President & CEO Sep 19 '23 Buy 12.62 15,000 189,370 15,000 Sep 19 09:47 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
